Abomics is a Finnish health technology company founded in 2013 by medical doctors that specializes in pharmacogenetics. We support healthcare professionals with pharmacogenetic solutions that enable precision medication. Pharmacogenetic testing helps identify more effective and safer medication and dosages, reducing trial-and-error prescribing and minimizing the risk of adverse drug reactions. Our solutions are designed to integrate seamlessly into clinical workflows bringing pharmacogenetic insights into everyday clinical decision-making. Built on scientific evidence and clinical expertise, we are a trusted partner to hospitals, laboratories, pharmaceutical companies, genomic service providers, and biobanks. Our PGx solutions: • Interpretation • Medical guidance • System integration • Medical databases • Consultation and education We work closely with each customer to deliver customisable solution that meets your needs in pharmacogenetics. Let’s take a next step in PGx together. 📩 Contact us: info@abomicspgx.com 🔗 Learn more: abomicspgx.com 📍 Based in Finland. Supporting healthcare providers globally. ✅ ISO 13485:2016 certified, ensuring safe, compliant, and high-quality pharmacogenetic services
| Website | https://abomicspgx.com/ |
| Employees | 19 (7 on RocketReach) |
| Founded | 2013 |
| Address | Yliopistonkatu 31, Turku, Southwest Finland 20100, FI |
| Phone | +358 50 3632200 |
| Industry | Hospitals and Health Care |
Looking for a particular Abomics employee's phone or email?
Sami Miettinen is the CEO of Abomics.
7 people are employed at Abomics.
Abomics is based in Turku, Southwest Finland.